Toward personalized medicine: Does genetic diagnosis of pediatric cardiomyopathy influence patient management?

Teresa M. Lee, Stephanie Ware

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A goal of personalized medicine is to provide increasingly sophisticated, individualized approaches to management and therapy for disease. Genetics is the engine that drives personalized medicine, holding the promise of therapeutics directed toward the unique needs of each patient. The 3<sup>rd</sup> International Conference on Cardiomyopathy in Children provided a forum to discuss the current status of personalized approaches to diagnosis, management, and therapy in the pediatric cardiomyopathy population. This review will focus on the importance of genetic diagnosis in this population as a necessary first step toward understanding the best approach to management and influencing disease outcome. The genetic heterogeneity of cardiomyopathy in children, the implications of specific genotypes, the ability to risk stratify based on genotype, and the impact on cascade screening in family members will be discussed.

Original languageEnglish
Pages (from-to)43-47
Number of pages5
JournalProgress in Pediatric Cardiology
Volume39
Issue number1
DOIs
StatePublished - Jul 1 2015

Fingerprint

Precision Medicine
Cardiomyopathies
Pediatrics
Disease Management
Genotype
Aptitude
Genetic Heterogeneity
Population
Therapeutics

Keywords

  • Cascade screening
  • Metabolic
  • Sarcomere
  • Syndrome

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pediatrics, Perinatology, and Child Health

Cite this

Toward personalized medicine : Does genetic diagnosis of pediatric cardiomyopathy influence patient management? / Lee, Teresa M.; Ware, Stephanie.

In: Progress in Pediatric Cardiology, Vol. 39, No. 1, 01.07.2015, p. 43-47.

Research output: Contribution to journalArticle

@article{21feda05b5f14e81afac8b57c162037d,
title = "Toward personalized medicine: Does genetic diagnosis of pediatric cardiomyopathy influence patient management?",
abstract = "A goal of personalized medicine is to provide increasingly sophisticated, individualized approaches to management and therapy for disease. Genetics is the engine that drives personalized medicine, holding the promise of therapeutics directed toward the unique needs of each patient. The 3rd International Conference on Cardiomyopathy in Children provided a forum to discuss the current status of personalized approaches to diagnosis, management, and therapy in the pediatric cardiomyopathy population. This review will focus on the importance of genetic diagnosis in this population as a necessary first step toward understanding the best approach to management and influencing disease outcome. The genetic heterogeneity of cardiomyopathy in children, the implications of specific genotypes, the ability to risk stratify based on genotype, and the impact on cascade screening in family members will be discussed.",
keywords = "Cascade screening, Metabolic, Sarcomere, Syndrome",
author = "Lee, {Teresa M.} and Stephanie Ware",
year = "2015",
month = "7",
day = "1",
doi = "10.1016/j.ppedcard.2015.01.008",
language = "English",
volume = "39",
pages = "43--47",
journal = "Progress in Pediatric Cardiology",
issn = "1058-9813",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Toward personalized medicine

T2 - Does genetic diagnosis of pediatric cardiomyopathy influence patient management?

AU - Lee, Teresa M.

AU - Ware, Stephanie

PY - 2015/7/1

Y1 - 2015/7/1

N2 - A goal of personalized medicine is to provide increasingly sophisticated, individualized approaches to management and therapy for disease. Genetics is the engine that drives personalized medicine, holding the promise of therapeutics directed toward the unique needs of each patient. The 3rd International Conference on Cardiomyopathy in Children provided a forum to discuss the current status of personalized approaches to diagnosis, management, and therapy in the pediatric cardiomyopathy population. This review will focus on the importance of genetic diagnosis in this population as a necessary first step toward understanding the best approach to management and influencing disease outcome. The genetic heterogeneity of cardiomyopathy in children, the implications of specific genotypes, the ability to risk stratify based on genotype, and the impact on cascade screening in family members will be discussed.

AB - A goal of personalized medicine is to provide increasingly sophisticated, individualized approaches to management and therapy for disease. Genetics is the engine that drives personalized medicine, holding the promise of therapeutics directed toward the unique needs of each patient. The 3rd International Conference on Cardiomyopathy in Children provided a forum to discuss the current status of personalized approaches to diagnosis, management, and therapy in the pediatric cardiomyopathy population. This review will focus on the importance of genetic diagnosis in this population as a necessary first step toward understanding the best approach to management and influencing disease outcome. The genetic heterogeneity of cardiomyopathy in children, the implications of specific genotypes, the ability to risk stratify based on genotype, and the impact on cascade screening in family members will be discussed.

KW - Cascade screening

KW - Metabolic

KW - Sarcomere

KW - Syndrome

UR - http://www.scopus.com/inward/record.url?scp=84938557521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938557521&partnerID=8YFLogxK

U2 - 10.1016/j.ppedcard.2015.01.008

DO - 10.1016/j.ppedcard.2015.01.008

M3 - Article

AN - SCOPUS:84938557521

VL - 39

SP - 43

EP - 47

JO - Progress in Pediatric Cardiology

JF - Progress in Pediatric Cardiology

SN - 1058-9813

IS - 1

ER -